Drugs and Medicaments: World Trade, Markets and Competitors

Drugs and Medicaments: World Trade, Markets and Competitors

In 2024 world trade of Drugs and Medicaments is estimated to record a value of 949.6 Bn $, with a positive trend (+11.6%) compared to 2023.

Worldwide flows of Drugs and Medicaments recorded a Compound Annual Growth Rate (CAGR) in $ of +23.9% in the period 2001-2008 and of +5.8% in the period 2009-2024.

In the 2025-2028 scenario, world trade of Drugs and Medicaments is expected to have a CAGR of +7.9% in $.

The report includes an analysis of 20 major importing countries of Drugs and Medicaments, as regards:

import size and evolution both in values and volumes over the period 1995-2024
import segmentation by price-ranges and evolution 2024 vs 2014
import shares and price positioning by partner countries (competitors) in 2019-2024
forecast of import values and shares by competitors up to 2028.

The report also includes an analysis of 20 major exporting countries of Drugs and Medicaments, as regards:

export size and evolution both in values and volumes over the period 1995-2023
export segmentation by price-ranges and evolution 2024 vs 2014
export shares and price positioning by destination countries (markets) in 2019-2024
forecast of export values and shares by markets up to 2028.

Information contained in this report is derived from the Ulisse Database, that was developed from the UN(Comtrade), Eurostat (db Comext) and US Census Bureau (db UsaTrade) databases.

The Ulisse Database basic unit is the Annual Flow of World Trade between two partner countries for Drugs and Medicaments.

Forecasts contained in this report have been developed by StudiaBo from the Ulisse Database andthe World Economic Outlook (WEO) database, periodically released by the International Monetary Fund.

Forecasts are the output of an integrated econometric model of demand and competitiveness, thatis based on expected macroeconomic trends and capacity of countries to compete in internationalmarkets. They provide a robust estimate of the scenario of Drugs and Medicaments’ world trade.